Citations (208)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Maria Hollmen, Tom Bromilow, Adam B Smith, Stuart Mealing, Damian Lewis, Liam Galvin, Steve Jones, Luís Pacheco, Stéphane Soulard & Antoine Froidure. (2023) I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options. Patient Preference and Adherence 17, pages 1621-1639.
Read now
Read now
Chunxian Piao, Chuanyu Zhuang, Min Kyung Ko, Do Won Hwang & Minhyung Lee. (2022) Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model. Journal of Drug Targeting 30:7, pages 792-799.
Read now
Read now
Nevins W. Todd, Sergei P. Atamas, Stella E. Hines, Irina G. Luzina, Nirav G. Shah, Edward J. Britt, Andrew J. Ghio & Jeffrey R. Galvin. (2022) Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease. Expert Review of Respiratory Medicine 16:2, pages 235-245.
Read now
Read now
Shambhu Aryal & Steven D. Nathan. (2018) An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Emerging Drugs 23:2, pages 159-172.
Read now
Read now
Joshua J. Mooney, Karina Raimundo, Eunice Chang & Michael S. Broder. (2017) Hospital cost and length of stay in idiopathic pulmonary fibrosis. Journal of Medical Economics 20:5, pages 518-524.
Read now
Read now
Nevins W Todd, Sergei P Atamas, Irina G Luzina & Jeffrey R Galvin. (2015) Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis. Expert Review of Respiratory Medicine 9:4, pages 411-418.
Read now
Read now
Yukiko Miura & Arata Azuma. (2015) Pirfenidone: an orphan drug for treating idiopathic pulmonary fibrosis. Expert Opinion on Orphan Drugs 3:5, pages 587-597.
Read now
Read now
Steven D Nathan & Christopher S King. (2014) Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?. Drug Design, Development and Therapy 8, pages 875-885.
Read now
Read now
Articles from other publishers (200)
Harshank Patel, Jui Rakesh Shah, Divya Rakeshkumar Patel, Chaithanya Avanthika, Sharan Jhaveri & Kunj Gor. (2023) Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols. Disease-a-Month 69:7, pages 101484.
Crossref
Crossref
Vincent Cottin, Philippe Bonniaud, Jacques Cadranel, Bruno Crestani, Stéphane Jouneau, Sylvain Marchand-Adam, Hilario Nunes, Lidwine Wémeau-Stervinou, Emmanuel Bergot, Elodie Blanchard, Raphaël Borie, Arnaud Bourdin, Cécile Chenivesse, Annick Clément, Emmanuel Gomez, Anne Gondouin, Sandrine Hirschi, François Lebargy, Charles-Hugo Marquette, David Montani, Grégoire Prévot, Sébastien Quetant, Martine Reynaud-Gaubert, Mathieu Salaun, Olivier Sanchez, Bruno Trumbic, Karim Berkani, Pierre-Yves Brillet, Marion Campana, Lara Chalabreysse, Gérard Chatté, Didier Debieuvre, Gilbert Ferretti, Jean-Michel Fourrier, Nicolas Just, Marianne Kambouchner, Bertrand Legrand, Frédéric Le Guillou, Jean-Pierre Lhuillier, Anas Mehdaoui, Jean-Marc Naccache, Catherine Paganon, Martine Rémy-Jardin, Salim Si-Mohamed & Philippe Terrioux. (2023) French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version. Respiratory Medicine and Research 83, pages 100948.
Crossref
Crossref
Marianna Štefániková, Martina Doubková, Petra Ovesná, Martina Šterclová, Ladislav Lacina, Monika Žurková, Martina Plačková, Vladimír Bartoš, Ivana Janíčková, Radka Bittenglová, Jan Anton, Ľubica Sýkorová, Vladimíra Lošťáková, Pavlína Musilová, Hana Šuldová, Radka Mokošová, Jurij Didyk, Lenka Šišáková, Pavlína Lisá, Jaroslav Lněnička, Hana Dařičková, Daniel Doležel, Jana Pšikalová, Richard Tyl, Renata Králová & Martina Koziar Vašáková. (2023) The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Caymen M. Novak, Shruthi Sethuraman, Kristina L. Luikart, Brenda F. Reader, Jana S. Wheat, Bryan Whitson, Samir N. Ghadiali & Megan N. Ballinger. (2023) Alveolar macrophages drive lung fibroblast function in cocultures of IPF and normal patient samples. American Journal of Physiology-Lung Cellular and Molecular Physiology 324:4, pages L507-L520.
Crossref
Crossref
Anoop Nambiar, Dean KelloggIIIIII, Jaime Justice, Martin Goros, Jonathan Gelfond, Rodolfo Pascual, Shahrukh Hashmi, Michal Masternak, Larissa Prata, Nathan LeBrasseur, Andrew Limper, Stephen Kritchevsky, Nicolas Musi, Tamara Tchkonia & James Kirkland. (2023) Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability. eBioMedicine 90, pages 104481.
Crossref
Crossref
Alyson W. Wong, Huiying Sun, Ingrid A. Cox, Jolene H. Fisher, Nasreen Khalil, Kerri A. Johannson, Veronica Marcoux, Deborah Assayag, Helene Manganas, Martin Kolb, Andrew J. Palmer, Barbara de Graaff, E. Haydn Walters, Peter Hopkins, Christopher Zappala, Nicole S. Goh, Yuben Moodley, Vidya Navaratnam, Tamera J. Corte, Christopher J. Ryerson & Wei Zhang. (2023) Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease. PLOS ONE 18:3, pages e0283110.
Crossref
Crossref
Tianxiao Sun, Haihua Li, Yan Zhang, Guixin Xiong, Yuerun Liang, Fang Lu, Rong Zheng, Qi Zou & Jiejie Hao. (2023) Inhibitory Effects of 3-Cyclopropylmethoxy-4-(difluoromethoxy) Benzoic Acid on TGF-β1-Induced Epithelial–Mesenchymal Transformation of In Vitro and Bleomycin-Induced Pulmonary Fibrosis In Vivo. International Journal of Molecular Sciences 24:7, pages 6172.
Crossref
Crossref
Mark P. SteeleAnna L. Peljto, Susan K. MathaiStephen Humphries, Tami J. Bang, Andrea OhShawn TeagueGiuseppe CicchettiChristopher Sigakis, Jonathan A. Kropski, James E. Loyd, Timothy S. Blackwell, Kevin K. Brown, Marvin I. SchwarzRachel A. WarrenJulia PowersAvram D. WaltsCheryl Markin, Tasha E. FingerlinIvana V. YangDavid A. LynchJoyce S. LeeDavid A. Schwartz. (2023) Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort. American Journal of Respiratory and Critical Care Medicine 207:5, pages 587-593.
Crossref
Crossref
Snigdha Jain, Leah J. Witt & Lauren E. Ferrante. (2022)
Clin‐STAR
corner: Recent
practice‐changing
studies at the interface of pulmonary and critical care medicine and geriatrics
. Journal of the American Geriatrics Society 71:3, pages 705-710.
Crossref
Crossref
Carl J Reynolds, Rupa Sisodia, Chris Barber, Miriam Moffatt, Cosetta Minelli, Sara De Matteis, John W Cherrie, Anthony Newman Taylor & Paul Cullinan. (2023) What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures case–control study. Occupational and Environmental Medicine 80:2, pages 97-103.
Crossref
Crossref
Louis-Philippe Boulet, Kim L. Lavoie, Chantal Raherison-Semjen, Alan Kaplan, Dave Singh & Christine R. Jenkins. (2022) Addressing sex and gender to improve asthma management. npj Primary Care Respiratory Medicine 32:1.
Crossref
Crossref
Kiran Dudhat & Harsha Patel. (2022) Preparation and evaluation of pirfenidone loaded chitosan nanoparticles pulmonary delivery for idiopathic pulmonary fibrosis. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
Ahmad Abu Qubo, Jamil Numan, Juan Snijder, Maria Padilla, John H.M. Austin, Kathleen M. Capaccione, Monica Pernia, Jean Bustamante, Timothy O'Connor & Mary M. Salvatore. (2023) Idiopathic pulmonary fibrosis and lung cancer: future directions and challenges. Breathe 18:4, pages 220147.
Crossref
Crossref
Fiorenzo Santoleri, Luigia Auriemma, Antonella Spacone, Stefano Marinari, Fabio Esposito, Francesco De Vita, Giovanni Petragnani, Caterina Di Fabio, Letizia Di Fabio & Alberto Costantini. (2021) Adherence, Persistence, and Effectiveness in Real Life. Multicenter Long-Term Study on the Use of Pirfenidone and Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis. Journal of Pharmacy Practice 35:6, pages 853-858.
Crossref
Crossref
Ali-Reza Mohammadi-Nejad, Richard J. Allen, Luke M. Kraven, Olivia C. Leavy, R. Gisli Jenkins, Louise V. Wain, Dorothee P. Auer & Stamatios N. Sotiropoulos. (2022) Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk. eBioMedicine 86, pages 104356.
Crossref
Crossref
Jiaxin Li, Xiaoxuan Zhai, Xiao Sun, Shengchuan Cao, Qiuhuan Yuan & Jiali Wang. (2022) Metabolic reprogramming of pulmonary fibrosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Ming Wang, Simin Lu, Hui Zhao, Ziyi Liu, Kangjia Sheng & Jiacheng Fang. (2022) Natural polysaccharides as potential anti-fibrotic agents: A review of their progress. Life Sciences 308, pages 120953.
Crossref
Crossref
Tao Huang & Hua-Fu Zhou. (2022) A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis. Computational and Mathematical Methods in Medicine 2022, pages 1-18.
Crossref
Crossref
Kaitlin Kelly‐Reif, Stephen Bertke, Robert D. Daniels, David B. Richardson & Mary K. Schubauer‐Berigan. (2022) Nonmalignant respiratory disease mortality in male Colorado Plateau uranium miners, 1960–2016. American Journal of Industrial Medicine 65:10, pages 773-782.
Crossref
Crossref
Yanrong Gu, Toby Lawrence, Rafeezul Mohamed, Yinming Liang & Badrul Hisham Yahaya. (2022) The emerging roles of interstitial macrophages in pulmonary fibrosis: A perspective from scRNA-seq analyses. Frontiers in Immunology 13.
Crossref
Crossref
Run Guo, Yuefei Zhou, Fang Lin, Mengxing Li, Chunting Tan & Bo Xu. (2022) A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis. Frontiers in Pharmacology 13.
Crossref
Crossref
V. Cottin, P. Bonniaud, J. Cadranel, B. Crestani, S. Jouneau, S. Marchand-Adam, H. Nunes, L. Wémeau-Stervinou, E. Bergot, E. Blanchard, R. Borie, A. Bourdin, C. Chenivesse, A. Clément, E. Gomez, A. Gondouin, S. Hirschi, F. Lebargy, C.-H. Marquette, D. Montani, G. Prévot, S. Quetant, M. Reynaud-Gaubert, M. Salaun, O. Sanchez, B. Trumbic, K. Berkani, P.-Y. Brillet, M. Campana, L. Chalabreysse, G. Chatté, D. Debieuvre, G. Ferretti, J.-M. Fourrier, N. Just, M. Kambouchner, B. Legrand, F. Le Guillou, J.-P. Lhuillier, A. Mehdaoui, J.-M. Naccache, C. Paganon, M. Rémy-Jardin, S. Si-Mohamed & P. Terrioux. (2022) Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version intégrale. Revue des Maladies Respiratoires 39:7, pages e35-e106.
Crossref
Crossref
David Zhang, Gundula Povysil, Philippe H. Kobeissy, Qi Li, Binhan Wang, Mason Amelotte, Hager Jaouadi, Chad A. Newton, Toby M. Maher, Philip L. MolyneauxImre NothFernando J. Martinez, Ganesh Raghu, Jamie L. Todd, Scott M. PalmerCarolina Haefliger, Adam Platt, Slavé Petrovski, Joseph A. Garcia, David B. GoldsteinChristine Kim Garcia. (2022)
Rare and Common Variants in
KIF15
Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis
. American Journal of Respiratory and Critical Care Medicine 206:1, pages 56-69.
Crossref
Crossref
Paola Confalonieri, Maria Concetta Volpe, Justin Jacob, Serena Maiocchi, Francesco Salton, Barbara Ruaro, Marco Confalonieri & Luca Braga. (2022) Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). Cells 11:13, pages 2095.
Crossref
Crossref
Gabrielle Y Liu, G R Scott Budinger & Jane E Dematte. (2022) Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. BMJ, pages e066354.
Crossref
Crossref
Tao Huang & Wei-Ying He. (2022) Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification. Frontiers in Genetics 13.
Crossref
Crossref
Pavitra Murthy, Nur Adania Shaibie, Chooi Ling Lim, Anna Pick Kiong Ling, Soi Moi Chye & Rhun Yian Koh. (2022) An Overview of Herbal Medicines for Idiopathic Pulmonary Fibrosis. Processes 10:6, pages 1131.
Crossref
Crossref
Mahsa Yavari, Seyed Ali Javad Mousavi, Leila Janani, Zahra Feizy & Mohammadreza Vafa. (2022) Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial. Clinical Nutrition ESPEN 49, pages 295-300.
Crossref
Crossref
Sai‐Nan Min, Meng‐Qi Zhu, Xiang‐Di Mao, Wei Li, Tai Wei, Mei Mei, Yan Zhang, Li‐Ling Wu, Guang‐Yan Yu & Xin Cong. (2022)
Contribution of Interleukin‐4–Induced Epithelial Cell Senescence to Glandular Fibrosis in
IgG4‐Related
Sialadenitis
. Arthritis & Rheumatology 74:6, pages 1070-1082.
Crossref
Crossref
Jiafeng Zheng, Hanquan Dong, Tongqiang Zhang, Jing Ning, Yongsheng Xu & Chunquan Cai. (2022) Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes. Frontiers in Genetics 13.
Crossref
Crossref
Adolf Koudelka, Veronika Cechova, Mauricio Rojas, Nilay Mitash, Anna Bondonese, Claudette St. Croix, Mark A. Ross & Bruce A. Freeman. (2022) Fatty acid nitroalkene reversal of established lung fibrosis. Redox Biology 50, pages 102226.
Crossref
Crossref
Jovito Cesar Santos-Álvarez, Juan Manuel Velázquez-Enríquez, Rosendo García-Carrillo, César Rodríguez-Beas, Alma Aurora Ramírez-Hernández, Edilburga Reyes-Jiménez, Karina González-García, Armando López-Martínez, Laura Pérez-Campos Mayoral, Sergio Roberto Aguilar-Ruiz, María de los Ángeles Romero-Tlalolini, Honorio Torres-Aguilar, Luis Castro-Sánchez, Jaime Arellanes-Robledo, Verónica Rocío Vásquez-Garzón & Rafael Baltiérrez-Hoyos. (2022) miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach. Cells 11:7, pages 1112.
Crossref
Crossref
Sonam KuchekarRupali Jadhav. (2022) Review on Idiopathic Pulmonary Fibrosis. Asian Journal of Research in Pharmaceutical Sciences, pages 42-48.
Crossref
Crossref
Raphael Borie, Pierre Le Guen, Mada Ghanem, Camille Taillé, Susan Mathai, Philippe Dieudé, Caroline Kannengiesser & Bruno Crestani. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
96
113
.
Ashish Garg, Sweta Garg, Prakash Pandey, Vijay Sagar Madamsetty & Neeraj Mishra. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
435
469
.
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
271
299
.
Xiaozheng Wu, Wen Li, Zhenliang Luo & Yunzhi Chen. (2021) The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis. Scientific Reports 11:1.
Crossref
Crossref
Donato Lacedonia, Giulia Scioscia, Piera Soccio, Massimo Conese, Lucia Catucci, Grazia P. Palladino, Filomena Simone, Carla M. I. Quarato, Sante Di Gioia, Roberto Rana, Francesco Sollitto & Maria P. Foschino-Barbaro. (2021) Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Katherine A. Cummins, Peter B. Bitterman, Daniel J. Tschumperlin & David K. Wood. (2021) A scalable 3D tissue culture pipeline to enable functional therapeutic screening for pulmonary fibrosis. APL Bioengineering 5:4.
Crossref
Crossref
Yasuhiko Koga, Takahiro Satoh, Kyoichi Kaira, Yoshimasa Hachisu, Yasuyuki Ishii, Toshiki Yajima, Takeshi Hisada, Hideaki Yokoo & Kunio Dobashi. (2021) Progression of Idiopathic Pulmonary Fibrosis Is Associated with Silica/Silicate Inhalation. Environmental Science & Technology Letters 8:10, pages 903-910.
Crossref
Crossref
Nazar Pryimak, Mariia Zaiachuk, Olga Kovalchuk & Igor Kovalchuk. (2021) The Potential Use of Cannabis in Tissue Fibrosis. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Gabrielle Y. Liu & Ravi Kalhan. (2021) Impaired Respiratory Health and Life Course Transitions From Health to Chronic Lung Disease. Chest 160:3, pages 879-889.
Crossref
Crossref
Yue Bai, Yunhao Zhang, Peng Chu, Changyuan Wang, Lei Li, Yan Qi, Xu Han, Baojing Zhang, Huijun Sun, Yanxia Li, Lixue Chen & Xiaodong Ma. (2021) Synthesis and biological evaluation of selenogefitinib for reducing bleomycin-induced pulmonary fibrosis. Bioorganic & Medicinal Chemistry Letters 48, pages 128238.
Crossref
Crossref
D. L. Kellogg3rd3rd, D. L. KelloggJrJr, N. Musi & A. M. Nambiar. (2021) Cellular Senescence in Idiopathic Pulmonary Fibrosis. Current Molecular Biology Reports 7:3, pages 31-40.
Crossref
Crossref
Syed Afroz Ali, Mohd Aslam Saifi, Chandraiah Godugu & Venu Talla. (2021) Silibinin alleviates silica‐induced pulmonary fibrosis: Potential role in modulating inflammation and epithelial‐mesenchymal transition. Phytotherapy Research 35:9, pages 5290-5304.
Crossref
Crossref
R. Carrington, S. Jordan, Y.J. Wong, S.C. Pitchford & C.P. Page. (2021) A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin. Journal of Pharmacological and Toxicological Methods 109, pages 107057.
Crossref
Crossref
Maoyan Wu, Huiwen Xu, Jingyu Liu, Xiaozhen Tan, Shengrong Wan, Man Guo, Yang Long & Yong Xu. (2021) Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms. Journal of Diabetes Research 2021, pages 1-11.
Crossref
Crossref
Sarah Denzler, Diem Vuong, Marta Bogowicz, Matea Pavic, Thomas Frauenfelder, Sandra Thierstein, Eric Innocents Eboulet, Britta Maurer, Janine Schniering, Hubert Szymon Gabryś, Isabelle Schmitt-Opitz, Miklos Pless, Robert Foerster, Matthias Guckenberger & Stephanie Tanadini-Lang. (2021) Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types. The British Journal of Radiology 94:1120, pages 20200947.
Crossref
Crossref
Yun-Li Zhao, Shi-Biao Pu, Yan Qi, Bai-Fen Wu, Jian-Hua Shang, Ya-Ping Liu, Di Hu & Xiao-Dong Luo. (2021) Pharmacological effects of indole alkaloids from Alstonia scholaris (L.) R. Br. on pulmonary fibrosis in vivo. Journal of Ethnopharmacology 267, pages 113506.
Crossref
Crossref
Syed Afroz Ali, Mohd Aslam Saifi, Gauthami Pulivendala, Chandraiah Godugu & Venu Talla. (2021) Ferulic acid ameliorates the progression of pulmonary fibrosis via inhibition of TGF-β/smad signalling. Food and Chemical Toxicology 149, pages 111980.
Crossref
Crossref
Thị Hằng Giang Phan, Panagiotis Paliogiannis, Gheyath K. Nasrallah, Roberta Giordo, Ali Hussein Eid, Alessandro Giuseppe Fois, Angelo Zinellu, Arduino Aleksander Mangoni & Gianfranco Pintus. (2020) Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cellular and Molecular Life Sciences 78:5, pages 2031-2057.
Crossref
Crossref
Görkem Türkkan, Yves Willems, Lizza E.L. Hendriks, Rémy Mostard, Lennart Conemans, Hester A Gietema, Cristina Mitea, Stéphanie Peeters & Dirk De Ruysscher. (2021) Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology. Radiotherapy and Oncology 155, pages 269-277.
Crossref
Crossref
Kevin Shenderov, Samuel L. Collins, Jonathan D. Powell & Maureen R. Horton. (2021) Immune dysregulation as a driver of idiopathic pulmonary fibrosis. Journal of Clinical Investigation 131:2.
Crossref
Crossref
Kum Ju Chae, Gong Yong Jin, Jin Mo Goo & Myoung Ja Chung. (2021) Interstitial Lung Abnormalities: What Radiologists Should Know. Korean Journal of Radiology 22:3, pages 454.
Crossref
Crossref
Hitesh Malhotra, Anjoo Kamboj & Rupesh K. Gautam. 2021. Medicinal Plants for Lung Diseases. Medicinal Plants for Lung Diseases
583
608
.
Banudevi Sivanantham & Vijayageetha Bose. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
287
310
.
Derek Dillane. 2021. Preoperative Assessment. Preoperative Assessment
101
106
.
An Thi Nhat Ho, Artem Shmelev & Edward Charbek. (2020) Trends and seasonal variation of hospitalization and mortality of interstitial lung disease in the United States from 2006 to 2016. Respiratory Research 21:1.
Crossref
Crossref
Tanja Tran, Martina Šterclová, Nesrin Mogulkoc, Katarzyna Lewandowska, Veronika Müller, Marta Hájková, Mordechai R. Kramer, Dragana Jovanović, Jasna Tekavec-Trkanjec, Michael Studnicka, Natalia Stoeva, Karel Hejduk, Ladislav Dušek, Samy Suissa & Martina Vašáková. (2020) The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis. Respiratory Research 21:1.
Crossref
Crossref
Nils Hoyer, Laura H. Thomsen, Mathilde M. W. Wille, Torgny Wilcke, Asger Dirksen, Jesper H. Pedersen, Zaigham Saghir, Haseem Ashraf & Saher B. Shaker. (2020) Increased respiratory morbidity in individuals with interstitial lung abnormalities. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Franck F. Rahaghi, Zeenat Safdar, Anne Whitney Brown, Joao A. de Andrade, Kevin R. Flaherty, Robert J. Kaner, Christopher S. King, Maria L. Padilla, Imre Noth, Mary Beth Scholand, Adrian Shifren & Steven D. Nathan. (2020) Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Rosella Ombrato, Lara Console, Benedetta Righino, Cesare Indiveri, Arduino Arduini & Maria Cristina De Rosa. (2020) Structure-based virtual screening to identify novel carnitine acetyltransferase activators. Journal of Molecular Graphics and Modelling 100, pages 107692.
Crossref
Crossref
Pooja Pandit, Rafael L. Perez & Jesse Roman. (2020) Sex-Based Differences in Interstitial Lung Disease. The American Journal of the Medical Sciences 360:5, pages 467-473.
Crossref
Crossref
Sergio Piñeiro-Hermida, Chiara Autilio, Paula Martínez, Fátima Bosch, Jesús Pérez-Gil & Maria A. Blasco. (2020) Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging. Journal of Cell Biology 219:10.
Crossref
Crossref
Michael J Abramson, Tsitsi Murambadoro, Sheikh M Alif, Geza P Benke, Shyamali C Dharmage, Ian Glaspole, Peter Hopkins, Ryan F Hoy, Sonja Klebe, Yuben Moodley, Shuli Rawson, Paul N Reynolds, Rory Wolfe, Tamera J Corte & E Haydn Walters. (2020) Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case–control study. Thorax 75:10, pages 864-869.
Crossref
Crossref
Elizabeth R. Volkmann, Donald P. Tashkin, Michael D. Roth, Ning Li, Julio Charles, Maureen Mayes, Grace Kim, Jonathan Goldin, Lila Pourzand, Philip J. Clements, Daniel E. Furst, Dinesh Khanna, Robert M. Elashoff & Shervin Assassi. (2020) The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis. Seminars in Arthritis and Rheumatism 50:5, pages 963-967.
Crossref
Crossref
Panagiota Naoum, Kostas Athanasakis, Anastasis Skroumpelos & John Kyriopoulos. (2020) Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece. Value in Health Regional Issues 22, pages 44-48.
Crossref
Crossref
Daniel S. Glass, David Grossfeld, Heather A. Renna, Priya Agarwala, Peter Spiegler, Lora J. Kasselman, Amy D. Glass, Joshua DeLeon & Allison B. Reiss. (2020) Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches. Respiratory Investigation 58:5, pages 320-335.
Crossref
Crossref
Raphael Borie, Caroline Kannengiesser, Clairelyne Dupin, Marie-Pierre Debray, Aurélie Cazes & Bruno Crestani. (2020) Impact of genetic factors on fibrosing interstitial lung diseases. Incidence and clinical presentation in adults. La Presse Médicale 49:2, pages 104024.
Crossref
Crossref
Allan R. Glanville. (2020) COUNTERPOINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? No. Chest 157:6, pages 1413-1414.
Crossref
Crossref
Joshua J. Solomon, Scott Matson, Lindsay B. Kelmenson, Jonathan H. Chung, Stephen B. Hobbs, Ivan O. Rosas, Paul F. Dellaripa, Tracy J. Doyle, Sergio Poli, Anthony J. Esposito, Ashley Visser, A. Itzam Marin, Isabelle Amigues, Evans R. Fernández Pérez, Kevin K. Brown, Michael Mahler, David Heinz, Carlyne Cool, Kevin D. Deane, Jeffrey J. Swigris & M. Kristen Demoruelle. (2020) IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis. Chest 157:6, pages 1513-1521.
Crossref
Crossref
Salvatore Sotgia, Alessandro G Fois, Elisabetta Sotgiu, Angelo Zinellu, Panagiotis Paliogiannis, Arduino A Mangoni & Ciriaco Carru. (2020) Micellar electrokinetic capillary chromatographic determination of pirfenidone and 5-carboxy-pirfenidone by direct injection of plasma from patients receiving treatment for idiopathic pulmonary fibrosis (IPF). Microchemical Journal 154, pages 104536.
Crossref
Crossref
Yoshinori Kawabata. 2020. Asbestos-related Diseases. Asbestos-related Diseases.
Gareth I. Walters. (2020) Occupational exposures and idiopathic pulmonary fibrosis. Current Opinion in Allergy & Clinical Immunology 20:2, pages 103-111.
Crossref
Crossref
Nicoleta Stefania MOTOC, Anca Diana MAIEREAN, Milena Adina MAN, Teodora Gabriela ALEXESCU, Lorena CIUMARNEAN, Claudia TONCA, Gabriela DOGARU, Doina Adina TODEA & Bianca DOMOKOS. (2020) The efficacy of pulmonary rehabilitation in improving the clinical status in
idiopathic pulmonary fibrosis. Balneo Research Journal:Vol.11, No1, pages 35-44.
Crossref
Crossref
Remus Şipoş & Emese Orban. (2020) The role and importance of the family doctor in the diagnosis of idiopathic pulmonary fibrosis. Medic.ro 3:135, pages 26.
Crossref
Crossref
Xiao Zhao, Jennifer Yin Yee Kwan, Kenneth Yip, Peter P. Liu & Fei-Fei Liu. (2019) Targeting metabolic dysregulation for fibrosis therapy. Nature Reviews Drug Discovery 19:1, pages 57-75.
Crossref
Crossref
Shweta U. Dhar & Sandesh C.S. Nagamani. 2020. Handbook of Clinical Adult Genetics and Genomics. Handbook of Clinical Adult Genetics and Genomics
325
338
.
Susan K. Mathai, David A. Schwartz & Raphael Borie. 2020. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics
405
437
.
Susan K. Mathai & David A. Schwartz. 2020. Precision in Pulmonary, Critical Care, and Sleep Medicine. Precision in Pulmonary, Critical Care, and Sleep Medicine
71
85
.
Amarnath Satheesh Marudamuthu, Yashodhar Prabhakar Bhandary, Liang Fan, Vijay Radhakrishnan, BreAnne MacKenzieEsther MaierShwetha Kumari Shetty, M.R. Nagaraja, Venkadesaperumal Gopu, Nivedita TiwariYajie Zhang, Alan B. Watts, Robert O. WilliamsIIIIII, Gerald J CrinerSudhir BollaNathaniel MarchettiSteven Idell & Sreerama Shetty. (2019) Caveolin-1–derived peptide limits development of pulmonary fibrosis. Science Translational Medicine 11:522.
Crossref
Crossref
Estrella Fernández-Fabrellas, María Molina-Molina, Joan B. Soriano, José Antonio Rodríguez Portal, Julio Ancochea, Claudia Valenzuela & Antoni Xaubet. (2019) Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry. Respiratory Research 20:1.
Crossref
Crossref
Nils Hoyer, Thomas Skovhus Prior, Elisabeth Bendstrup, Torgny Wilcke & Saher Burhan Shaker. (2019) Risk factors for diagnostic delay in idiopathic pulmonary fibrosis. Respiratory Research 20:1.
Crossref
Crossref
Adam M. Collison, Junyao Li, Ana Pereira de Siqueira, Xuejiao Lv, Hamish D. Toop, Jonathan C. Morris, Malcolm R. Starkey, Philip M. Hansbro, Jie Zhang & Joerg Mattes. (2019) TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis. BMC Pulmonary Medicine 19:1.
Crossref
Crossref
Susan K Mathai, Stephen Humphries, Jonathan A Kropski, Timothy S Blackwell, Julia Powers, Avram D Walts, Cheryl Markin, Julia Woodward, Jonathan H Chung, Kevin K Brown, Mark P Steele, James E Loyd, Marvin I Schwarz, Tasha Fingerlin, Ivana V Yang, David A Lynch & David A Schwartz. (2019)
MUC5B
variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis
. Thorax 74:12, pages 1131-1139.
Crossref
Crossref
Rola Harmouche, Samuel Y. Ash, Rachel K. Putman, Gary M. Hunninghake, Ruben San Jose Estepar, Fernando J. Martinez, Augustine M. Choi, David A. Lynch, Hiroto Hatabu, MeiLan K. Han, Russell P. Bowler, Ravi Kalhan, Ivan O. Rosas, George R. Washko & Raul San Jose Estepar. (2019) Objectively Measured Chronic Lung Injury on Chest CT. Chest 156:6, pages 1149-1159.
Crossref
Crossref
Andrew H. Limper. (2019) The Role of Surgical Lung Biopsy in Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 200:9, pages 1084-1085.
Crossref
Crossref
Richard H. Kimura, Ling Wang, Bin Shen, Li Huo, Willemieke Tummers, Fabian V. Filipp, Haiwei Henry Guo, Thomas Haywood, Lotfi Abou-Elkacem, Lucia Baratto, Frezghi Habte, Rammohan Devulapally, Timothy H. Witney, Yan Cheng, Suhas Tikole, Subhendu Chakraborti, Jay Nix, Christopher A. Bonagura, Negin Hatami, Joshua J. Mooney, Tushar Desai, Scott Turner, Richard S. Gaster, Andrea Otte, Brendan C. Visser, George A. Poultsides, Jeffrey Norton, Walter Park, Mark Stolowitz, Kenneth Lau, Eric Yang, Arutselvan Natarajan, Ohad Ilovich, Shyam Srinivas, Ananth Srinivasan, Ramasamy Paulmurugan, Juergen Willmann, Frederick T. Chin, Zhen Cheng, Andrei Iagaru, Fang Li & Sanjiv S. Gambhir. (2019) Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nature Communications 10:1.
Crossref
Crossref
V. L. J. Proesmans, M. Drent, M. D. P. Elfferich, P. A. H. M. Wijnen, N. T. Jessurun & A. Bast. (2019) Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients. Lung 197:5, pages 551-558.
Crossref
Crossref
Raphael Borie, Pierre Le Guen, Mada Ghanem, Camille Taillé, Clairelyne Dupin, Philippe Dieudé, Caroline Kannengiesser & Bruno Crestani. (2019) The genetics of interstitial lung diseases. European Respiratory Review 28:153, pages 190053.
Crossref
Crossref
Hasancan Bilgili, Adam J. Białas, Paweł Górski & Wojciech J. Piotrowski. (2019) Telomere Abnormalities in the Pathobiology of Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine 8:8, pages 1232.
Crossref
Crossref
Yang Zhang, Hao Jiao, Yu Wu & Xia Sun. (2019) P120-catenin regulates pulmonary fibrosis and TGF-β induced lung fibroblast differentiation. Life Sciences 230, pages 35-44.
Crossref
Crossref
Susan K. Mathai & David A. Schwartz. (2019) Translational research in pulmonary fibrosis. Translational Research 209, pages 1-13.
Crossref
Crossref
Qinghua Zhang, Yan Wang, Danhua Qu, Jinyan Yu & Junling Yang. (2019)
The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering
MUC5B
. BioMed Research International 2019, pages 1-12.
Crossref
Crossref
Giovanni Ferrara, Lisen Arnheim-Dahlström, Karen Bartley, Christer Janson, Klaus-Uwe Kirchgässler, Aaron Levine & C. Magnus Sköld. (2019) Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden. Pulmonary Therapy 5:1, pages 55-68.
Crossref
Crossref
Augustine Chung, James English & Elizabeth R. Volkmann. (2019) Interstitial Lung Disease in Systemic Sclerosis: Lessons Learned from Idiopathic Pulmonary Fibrosis. Current Treatment Options in Rheumatology 5:2, pages 127-146.
Crossref
Crossref
Yosafe Wakwaya & Kevin K. Brown. (2019) Idiopathic Pulmonary Fibrosis: Epidemiology, Diagnosis andOutcomes. The American Journal of the Medical Sciences 357:5, pages 359-369.
Crossref
Crossref
Andrew Barros, Justin Oldham & Imre Noth. (2019) Genetics of Idiopathic Pulmonary Fibrosis. The American Journal of the Medical Sciences 357:5, pages 379-383.
Crossref
Crossref
Warda Khamis, Olivia Freynet, Lucile Sese, Jean-François Bernaudin & Hilario Nunes. (2019) Prognostic Impact of Mediastinal Lymph Nodes in Interstitial Lung Diseases: Is Environmental Exposure the Offender?. American Journal of Respiratory and Critical Care Medicine 199:8, pages 1040-1041.
Crossref
Crossref
Luca Richeldi, Naomi Launders, Fernando Martinez, Simon L.F. Walsh, Jeffrey Myers, Bonnie Wang, Mark Jones, Alison Chisholm & Kevin R. Flaherty. (2019) The characterisation of interstitial lung disease multidisciplinary team meetings: a global study. ERJ Open Research 5:2, pages 00209-2018.
Crossref
Crossref
Jinbang Guo, William D. Hardie, Zackary I. Cleveland, Cynthia Davidson, Xuefeng Xu, Satish K. Madala & Jason C. Woods. (2019) Longitudinal free-breathing MRI measurement of murine lung physiology in a progressive model of lung fibrosis. Journal of Applied Physiology 126:4, pages 1138-1149.
Crossref
Crossref
Yaqiong Tian, Hui Li, Ting Qiu, Jinghong Dai, Yingwei Zhang, Jingyu Chen & Hourong Cai. (2018) Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF‐κB activation. Aging Cell 18:1.
Crossref
Crossref
Jamie N. Justice, Anoop M. Nambiar, Tamar Tchkonia, Nathan K. LeBrasseur, Rodolfo Pascual, Shahrukh K. Hashmi, Larissa Prata, Michal M. Masternak, Stephen B. Kritchevsky, Nicolas Musi & James L. Kirkland. (2019) Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine 40, pages 554-563.
Crossref
Crossref
Jutaro Fukumoto, Joseph Leung, Ruan CoxJrJr, Alexander Czachor, Prasanna Tamarapu Parthasarathy, Venu Lagishetty, Maria Mandry, Nima Hosseinian, Priyanshi Patel, Brittany Perry, Mason T. Breitzig, Matthew Alleyn, Athena Failla, Young Cho, Andrew J. Cooke, Lakshmi Galam, Ramani Soundararajan, Nirmal Sharma, Richard F. Lockey & Narasaiah Kolliputi. (2019) Oxidative stress induces club cell proliferation and pulmonary fibrosis in Atp8b1 mutant mice. Aging 11:1, pages 209-229.
Crossref
Crossref
S.R. Sousa, P. Caetano Mota, N. Melo, H.N. Bastos, E. Padrão, J.M. Pereira, R. Cunha, C. Souto Moura, S. Guimarães & A. Morais. (2019) Heterozygous TERT gene mutation associated with familial idiopathic pulmonary fibrosis. Respiratory Medicine Case Reports 26, pages 118-122.
Crossref
Crossref
Vineela Parvathaneni, Snehal K. Shukla & Vivek Gupta. 2019. Fibrosis in Disease. Fibrosis in Disease
197
237
.
Kui-Jun Chen, Qing Li, Chang-Mei Weng, Zhao-Xia Duan, Dong-Dong Zhang, Zhi-Qiang Chen, Jing Chen & Jian-Min Wang. (2018) Bleomycin-enhanced alternative splicing of fibroblast growth factor receptor 2 induces epithelial to mesenchymal transition in lung fibrosis. Bioscience Reports 38:6.
Crossref
Crossref
Joo Heung Yoon, Mehdi Nouraie, Xiaoping Chen, Richard H Zou, Jacobo Sellares, Kristen L Veraldi, Jared Chiarchiaro, Kathleen Lindell, David O Wilson, Naftali Kaminski, Timothy Burns, Humberto Trejo Bittar, Samuel Yousem, Kevin Gibson & Daniel J Kass. (2018) Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data. Respiratory Research 19:1.
Crossref
Crossref
Lauren Headley, Weizhen Bi, Cory Wilson, Scott D. Collum, Melissa Chavez, Tamara Darwiche, Tinne C. J. Mertens, Adriana M. Hernandez, Saad R. Siddiqui, Stephanie Rosenbaum, Richard A. Johnston & Harry Karmouty-Quintana. (2018) Low-dose administration of bleomycin leads to early alterations in lung mechanics. Experimental Physiology 103:12, pages 1692-1703.
Crossref
Crossref
Or Kalchiem-Dekel, Jeffrey Galvin, Allen Burke, Sergei Atamas & Nevins Todd. (2018) Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History. Journal of Clinical Medicine 7:12, pages 476.
Crossref
Crossref
Justin C. Hewlett, Jonathan A. Kropski & Timothy S. Blackwell. (2018) Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets. Matrix Biology 71-72, pages 112-127.
Crossref
Crossref
Michael J. Podolsky, Deepti Gupta, Arnold Ha, Ryan Ta, Amin Khalifeh-Soltani, William McKleroy, Ritwik Datta, Dean Sheppard & Kamran Atabai. (2018) Cell division cycle 7 kinase is a negative regulator of cell-mediated collagen degradation. American Journal of Physiology-Lung Cellular and Molecular Physiology 315:3, pages L360-L370.
Crossref
Crossref
Vishwaraj Sontake, Rajesh K. Kasam, Debora Sinner, Thomas R. Korfhagen, Geereddy B. Reddy, Eric S. White, Anil G. Jegga & Satish K. Madala. (2018) Wilms’ tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease. JCI Insight 3:16.
Crossref
Crossref
R. Carrington, S. Jordan, S.C. Pitchford & C.P. Page. (2018) Use of animal models in IPF research. Pulmonary Pharmacology & Therapeutics 51, pages 73-78.
Crossref
Crossref
Amy Dressen, Alexander R Abbas, Christopher Cabanski, Janina Reeder, Thirumalai R Ramalingam, Margaret Neighbors, Tushar R Bhangale, Matthew J Brauer, Julie Hunkapiller, Jens Reeder, Kiran Mukhyala, Karen Cuenco, Jennifer Tom, Amy Cowgill, Jan Vogel, William F Forrest, Harold R Collard, Paul J Wolters, Jonathan A Kropski, Lisa H Lancaster, Timothy S Blackwell, Joseph R Arron & Brian L Yaspan. (2018) Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study. The Lancet Respiratory Medicine 6:8, pages 603-614.
Crossref
Crossref
Dhamotharan Pattarayan, Ayyanar Sivanantham, Ramalingam Bethunaickan, Rajaguru Palanichamy & Subbiah Rajasekaran. (2018) Tannic acid modulates fibroblast proliferation and differentiation in response to pro‐fibrotic stimuli. Journal of Cellular Biochemistry 119:8, pages 6732-6742.
Crossref
Crossref
Cecilia López-Ramírez, Lionel Suarez Valdivia & Jose Rodríguez Portal. (2018) Causes of Pulmonary Fibrosis in the Elderly. Medical Sciences 6:3, pages 58.
Crossref
Crossref
Tsukasa Okamoto, Susan K. Mathai, Corinne E. Hennessy, Laura A. Hancock, Avram D. Walts, Adrianne L. Stefanski, Kevin K. Brown, David A. Lynch, Gregory P. Cosgrove, Steve D. Groshong, Carlyne D. Cool, Marvin I. Schwarz, Nirmal K. Banda, Joshua M. Thurman, Ivana V. Yang, V. Michael Holers & David A. Schwartz. (2018) The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 315:1, pages L1-L10.
Crossref
Crossref
Jade Jaffar, Soung-Hee Yang, Sally Yunsun Kim, Hae-Won Kim, Alen Faiz, Wojciech Chrzanowski & Janette K. Burgess. (2018) Greater cellular stiffness in fibroblasts from patients with idiopathic pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 315:1, pages L59-L65.
Crossref
Crossref
Gracijela Bozovic, Catharina Adlercreutz, Isabella M Björkman-Burtscher, Peter Reinstrup, Richard Ingemansson, Elin Skansebo & Mats Geijer. (2018) Impact of donor chest radiography on clinical outcome after lung transplantation. Acta Radiologica Open 7:6, pages 205846011878141.
Crossref
Crossref
Michelle Vega-Olivo & Gerard J. Criner. (2018) Idiopathic pulmonary fibrosis. The Nurse Practitioner 43:5, pages 48-54.
Crossref
Crossref
Michela Terlizzi, Antonio Molino, Chiara Colarusso, Chantal Donovan, Pasquale Imitazione, Pasquale Somma, Rita P. Aquino, Philip M. Hansbro, Aldo Pinto & Rosalinda Sorrentino. (2018) Activation of the Absent in Melanoma 2 Inflammasome in Peripheral Blood Mononuclear Cells From Idiopathic Pulmonary Fibrosis Patients Leads to the Release of Pro-Fibrotic Mediators. Frontiers in Immunology 9.
Crossref
Crossref
Anandharajan Rathinasabapathy, Alana Horowitz, Kelsey Horton, Ashok Kumar, Santhi Gladson, Thomas Unger, Diana Martinez, Gaurav Bedse, James West, Mohan K. Raizada, Ulrike M. Steckelings, Colin Sumners, Michael J. Katovich & Vinayak Shenoy. (2018) The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury. Frontiers in Physiology 9.
Crossref
Crossref
Luis R. Rodriguez, Margaret Emblom-Callahan, Mantej Chhina, Sarah Bui, Bilal Aljeburry, Luc H. Tran, Rebecca Novak, Merte Lemma, Steven D. Nathan & Geraldine M. Grant. (2018) Global Gene Expression Analysis in an in vitro Fibroblast Model of Idiopathic Pulmonary Fibrosis Reveals Potential Role for CXCL14/CXCR4. Scientific Reports 8:1.
Crossref
Crossref
Silvia Barril, Ana Alonso, José Antonio Rodríguez-Portal, Margarita Viladot, Jordi Giner, Francisco Aparicio, Ana Romero-Ortiz, Orlando Acosta & Diego Castillo. (2018) Cuidados paliativos en la enfermedad pulmonar intersticial difusa: resultados de una encuesta de ámbito nacional. Archivos de Bronconeumología 54:3, pages 123-127.
Crossref
Crossref
Silvia Barril, Ana Alonso, José Antonio Rodríguez-Portal, Margarita Viladot, Jordi Giner, Francisco Aparicio, Ana Romero-Ortiz, Orlando Acosta & Diego Castillo. (2018) Palliative Care in Diffuse Interstitial Lung Disease: Results of a Spanish Survey. Archivos de Bronconeumología (English Edition) 54:3, pages 123-127.
Crossref
Crossref
Bruce D Uhal, Amal Abdul-Hafez, Tarek Mohamed, Hanan Omar & Mohamed Shemis. (2018) The renin angiotensin system in liver and lung: impact and therapeutic potential in organ fibrosis. Journal of Lung, Pulmonary & Respiratory Research 5:1.
Crossref
Crossref
Paul J Wolters, Timothy S Blackwell, Oliver Eickelberg, James E Loyd, Naftali Kaminski, Gisli Jenkins, Toby M Maher, Maria Molina-Molina, Paul W Noble, Ganesh Raghu, Luca Richeldi, Marvin I Schwarz, Moises Selman, Wim A Wuyts & David A Schwartz. (2018) Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?. The Lancet Respiratory Medicine 6:2, pages 154-160.
Crossref
Crossref
Dominic C. Marshall, Justin D. Salciccioli, Barry S. Shea & Praveen Akuthota. (2018) Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013. European Respiratory Journal 51:1, pages 1701603.
Crossref
Crossref
Fotios Drakopanagiotakis & Philipp Markart. (2018) Interstitielle Lungenerkrankungen: epidemiologische Herausforderungen, Register und Biobanken. Kompass Pneumologie 6:2, pages 70-75.
Crossref
Crossref
Lisa H. Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler & Ulrich Costabel. (2017) Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis. European Respiratory Review 26:146, pages 170057.
Crossref
Crossref
Ryan D. Clay, Vivek N. Iyer, Dereddi Raja Reddy, Brittany Siontis & Paul D. Scanlon. (2017) The “Complex Restrictive” Pulmonary Function Pattern. Chest 152:6, pages 1258-1265.
Crossref
Crossref
Se Yeong Kim, Dong Mug Kang, Hyun Kyung Lee, Kun Hyung Kim & Junghye Choi. (2017) Occupational and Environmental Risk Factors for Chronic Fibrosing idiopathic Interstitial Pneumonia in South Korea. Journal of Occupational & Environmental Medicine 59:11, pages e221-e226.
Crossref
Crossref
Fernando J. Martinez, Harold R. Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J. Swigris, Hiroyuki Taniguchi & Athol U. Wells. (2017) Idiopathic pulmonary fibrosis. Nature Reviews Disease Primers 3:1.
Crossref
Crossref
Aladdin J. Mohammad, Kristian H. Mortensen, Judith Babar, Rona Smith, Rachel B. Jones, Daiki Nakagomi, Pasupathy Sivasothy & David R.W. Jayne. (2017) Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA Subtype. The Journal of Rheumatology 44:10, pages 1458-1467.
Crossref
Crossref
Huan Liu, Claudia Jakubzick, Andrew R. Osterburg, Rebecca L. Nelson, Nishant Gupta, Francis X. McCormack & Michael T. Borchers. (2017) Dendritic Cell Trafficking and Function in Rare Lung Diseases. American Journal of Respiratory Cell and Molecular Biology 57:4, pages 393-402.
Crossref
Crossref
Kentaro Fujiwara, Tetsu Kobayashi, Hajime Fujimoto, Hiroki Nakahara, Corina N. D'Alessandro-Gabazza, Josephine A. Hinneh, Yoshinori Takahashi, Taro Yasuma, Kota Nishihama, Masaaki Toda, Masahiro Kajiki, Yoshiyuki Takei, Osamu Taguchi & Esteban C. Gabazza. (2017) Inhibition of Cell Apoptosis and Amelioration of Pulmonary Fibrosis by Thrombomodulin. The American Journal of Pathology 187:10, pages 2312-2322.
Crossref
Crossref
Wencheng Yu, Liyun Mi & Teng Long. (2017) Efficacies of rosiglitazone and retinoin on bleomycin-induced pulmonary fibrosis in rats. Experimental and Therapeutic Medicine 14:1, pages 609-615.
Crossref
Crossref
Marina Aiello, Giuseppina Bertorelli, Marialuisa Bocchino, Alfredo Chetta, Alfeo Fiore-Donati, Alessandro Fois, Stefano Marinari, Tiberio Oggionni, Biagio Polla, Elisabetta Rosi, Anna Stanziola, Francesco Varone & Alessandro Sanduzzi. (2017) The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics 44, pages 7-15.
Crossref
Crossref
Hongge MaShupei QiaoZeli WangShuai Geng, Yufang ZhaoXiaolu HouWeiming TianXiongbiao Chen & Lifen Yao. (2017) Microencapsulation of Lefty-secreting engineered cells for pulmonary fibrosis therapy in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 312:5, pages L741-L747.
Crossref
Crossref
Sheetu Singh, Bridget F. Collins, Bharat B. Sharma, Jyotsna M. Joshi, Deepak Talwar, Sandeep Katiyar, Nishtha Singh, Lawrence Ho, Jai Kumar Samaria, Parthasarathi Bhattacharya, Rakesh Gupta, Sudhir Chaudhari, Tejraj Singh, Vijay Moond, Sudhakar Pipavath, Jitesh Ahuja, Ravindran Chetambath, Aloke G. Ghoshal, Nirmal K. Jain, H. J. Gayathri Devi, Surya Kant, Parvaiz Koul, Raja Dhar, Rajesh Swarnakar, Surendra K. Sharma, Dhrubajyoti J. Roy, Kripesh R. Sarmah, Bhavin Jankharia, Rodney Schmidt, Santosh K. Katiyar, Arpita Jindal, Daya K. Mangal, Virendra Singh & Ganesh Raghu. (2017) Interstitial Lung Disease in India. Results of a Prospective Registry. American Journal of Respiratory and Critical Care Medicine 195:6, pages 801-813.
Crossref
Crossref
Gracijela Bozovic, Catharina Adlercreutz, Peter Höglund, Isabella Björkman-Burtscher, Peter Reinstrup, Richard Ingemansson, Cornelia Schaefer-Prokop, Roger Siemund & Mats Geijer. (2017) Imaging of the Lungs in Organ Donors and its Clinical Relevance. Journal of Thoracic Imaging 32:2, pages 107-114.
Crossref
Crossref
Ana L. Mora, Marta Bueno & Mauricio Rojas. (2017) Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis. Journal of Clinical Investigation 127:2, pages 405-414.
Crossref
Crossref
Samuel Y Ash & George R Washko. (2017) Interstitial lung abnormalities: risk and opportunity. The Lancet Respiratory Medicine 5:2, pages 95-96.
Crossref
Crossref
Wupeng Liao, Jinrui Dong, Hong Peh, Lay Tan, Kah Lim, Li Li & Wai-Shiu Wong. (2017) Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases. Molecules 22:1, pages 139.
Crossref
Crossref
Meng Li, Ya Li, JianSheng Li, Peng Zhao, Yunping Bai, SuXiang Feng, Xuefang Liu, Yang Wang, Qingqing Bian & Junzi Li. (2017)
Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-
κ
B Signaling
. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-16.
Crossref
Crossref
Haruhiko YanagisawaMitsuo HashimotoShunsuke MinagawaNaoki TakasakaRoyce MaCatherine MoermansSaburo ItoJun Araya, Alison Budelsky, Amanda GoodsellJody L. BaronStephen L. Nishimura. (2017) Role of IL-17A in murine models of COPD airway disease. American Journal of Physiology-Lung Cellular and Molecular Physiology 312:1, pages L122-L130.
Crossref
Crossref
Satish Totey. 2017. Regenerative Medicine: Laboratory to Clinic. Regenerative Medicine: Laboratory to Clinic
511
529
.
Cormac McCarthy, Beatriz Lara Gallego, Bruce C. Trapnell & Francis X. McCormack. 2017. Rare Diseases Epidemiology: Update and Overview. Rare Diseases Epidemiology: Update and Overview
419
442
.
Alan Betensley, Rabab Sharif & Dimitrios Karamichos. (2016) A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine 6:1, pages 2.
Crossref
Crossref
Hanna M. Nurmi, Minna K. Purokivi, Miia S. Kärkkäinen, Hannu-Pekka Kettunen, Tuomas A. Selander & Riitta L. Kaarteenaho. (2016) Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Karina Raimundo, Eunice Chang, Michael S. Broder, Kimberly Alexander, James Zazzali & Jeffrey J. Swigris. (2016) Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Susan K Mathai, Chad A Newton, David A Schwartz & Christine Kim Garcia. (2016) Pulmonary fibrosis in the era of stratified medicine. Thorax 71:12, pages 1154-1160.
Crossref
Crossref
Jutaro Fukumoto, Ramani Soundararajan, Joseph Leung, Ruan CoxJr.Jr., Sanjay Mahendrasah, Neha Muthavarapu, Travis Herrin, Alexander Czachor, Lee C. Tan, Nima Hosseinian, Priyanshi Patel, Jayanthraj Gone, Mason T. Breitzig, Young Cho, Andrew J. Cooke, Lakshmi Galam, Venkata Ramireddy Narala, Yashwant Pathak, Richard F. Lockey & Narasaiah Kolliputi. (2016) The role of club cell phenoconversion and migration in idiopathic pulmonary fibrosis. Aging 8:11, pages 3091-3109.
Crossref
Crossref
Sophie Wecht & Mauricio Rojas. (2016) Mesenchymal stem cells in the treatment of chronic lung disease. Respirology 21:8, pages 1366-1375.
Crossref
Crossref
Dikshya Bastakoty & Pampee P. Young. (2016) Wnt/β‐catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration. The FASEB Journal 30:10, pages 3271-3284.
Crossref
Crossref
Ji Yhee, Jintaek Im & Richard Nho. (2016) Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery. Journal of Clinical Medicine 5:9, pages 82.
Crossref
Crossref
Ning-Yuan ChenScott D. CollumFayong LuoTingting WengThuy-Trahn LeAdriana M. HernandezKemly PhilipJose G. MolinaLuis J. Garcia-MoralesYanna CaoTien C. KoJavier Amione-GuerraOdeaa Al-JabbariRaquel R. BungeKeith YoukerBrian A. BrucknerRizwan Hamid, Jonathan Davies, Neeraj SinhaHarry Karmouty-Quintana. (2016) Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 311:2, pages L238-L254.
Crossref
Crossref
Yelizaveta Torosyan, Yuzhi Hu, Sarah Hoffman, Qianlai Luo, Bruce Carleton & Danica Marinac-Dabic. (2016) An in silico framework for integrating epidemiologic and genetic evidence with health care applications: ventilation-related pneumothorax as a case illustration. Journal of the American Medical Informatics Association 23:4, pages 711-720.
Crossref
Crossref
Robert Brownell, Naftali Kaminski, Prescott G. Woodruff, Williamson Z. Bradford, Luca Richeldi, Fernando J. Martinez & Harold R. Collard. (2016) Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 193:11, pages 1213-1218.
Crossref
Crossref
Xiang Zhou, Tian Gao, Xiao-Gang Jiang & Mei-Lin Xie. (2016) Protective effect of apigenin on bleomycin-induced pulmonary fibrosis in mice by increments of lung antioxidant ability and PPARγ expression. Journal of Functional Foods 24, pages 382-389.
Crossref
Crossref
Irina G. Luzina, Virginia Lockatell, Sang W. Hyun, Pavel Kopach, Phillip H. Kang, Zahid Noor, Anguo Liu, Erik P. Lillehoj, Chunsik Lee, Alba Miranda-Ribera, Nevins W. Todd, Simeon E. Goldblum & Sergei P. Atamas. (2016) Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 310:10, pages L940-L954.
Crossref
Crossref
Marius M Hoeper, Marc Humbert, Rogerio Souza, Majdy Idrees, Steven M Kawut, Karen Sliwa-Hahnle, Zhi-Cheng Jing & J Simon R Gibbs. (2016) A global view of pulmonary hypertension. The Lancet Respiratory Medicine 4:4, pages 306-322.
Crossref
Crossref
Michael Kreuter, Svenja Ehlers-Tenenbaum, Karin Palmowski, Jacques Bruhwyler, Ute Oltmanns, Thomas Muley, Claus Peter Heussel, Arne Warth, Martin Kolb & Felix J. F. Herth. (2016) Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis. PLOS ONE 11:3, pages e0151425.
Crossref
Crossref
Ahmed Bayoumi, Amer Sayed, Zuzana Broskova, Jian-Peng Teoh, James Wilson, Huabo Su, Yao-Liang Tang & Il-man Kim. (2016) Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease. International Journal of Molecular Sciences 17:3, pages 356.
Crossref
Crossref
C. M. Barber, R. E. Wiggans, C. Young & D. Fishwick. (2016) UK asbestos imports and mortality due to idiopathic pulmonary fibrosis. Occupational Medicine 66:2, pages 106-111.
Crossref
Crossref
C. Robalo Cordeiro, P. Campos, L. Carvalho, S. Campainha, S. Clemente, L. Figueiredo, J.M. Jesus, A. Marques, C. Souto-Moura, R. Pinto Basto, A. Ribeiro, M. Serrado & A. Morais. (2016) Consensus document for the diagnosis and treatment of idiopathic pulmonary fibrosis. Revista Portuguesa de Pneumologia (English Edition) 22:2, pages 112-122.
Crossref
Crossref
Sergio Harari, Fabiana Madotto, Antonella Caminati, Sara Conti & Giancarlo Cesana. (2016) Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy. PLOS ONE 11:2, pages e0147072.
Crossref
Crossref
Emily Fraser & Rachel K Hoyles. (2016) Therapeutic advances in idiopathic pulmonary fibrosis. Clinical Medicine 16:1, pages 42-51.
Crossref
Crossref
Li Peng, Yong Zhou, Liang Dong, Rui-Qi Chen, Guo-Ying Sun, Tian Liu, Wen-Zhuo Ran, Xiang Fang, Jian-Xin Jiang & Cha-Xiang Guan. (2016) TGF-β1 Upregulates the Expression of Triggering Receptor Expressed on Myeloid Cells 1 in Murine Lungs. Scientific Reports 6:1.
Crossref
Crossref
José Iván Betanzos-Paz, Mayra Edith Mejía-Ávila & Ivette Buendía-Roldán. (2016) La codificación CIE-10 en la enfermedad pulmonar intersticial en el Instituto Nacional de Enfermedades Respiratorias (INER) ¿sigue siendo aplicable?. NCT Neumología y Cirugía de Tórax 75:4, pages 263-267.
Crossref
Crossref
Mayra Mejía, Ivette Buendía-Roldán, Heidegger Mateos-Toledo, Anadrea Estrada, Manuel Espinoza-Hernández, Fortunato Juárez-Hernández, Claudia Vargas-Domínguez & Moisés Selman. (2016) Primer Consenso Mexicano sobre Fibrosis Pulmonar Idiopática. NCT Neumología y Cirugía de Tórax 75:1, pages 32-51.
Crossref
Crossref
Lei WangYimin SongXiankui LiHaizhou GuoGuojun Zhang. (2016) Role of thioredoxin nitration in bleomycin-induced pulmonary fibrosis in rats. Canadian Journal of Physiology and Pharmacology 94:1, pages 59-64.
Crossref
Crossref
Ena Ray BanerjeeEna Ray Banerjee. 2016. Perspectives in Translational Research in Life Sciences and Biomedicine. Perspectives in Translational Research in Life Sciences and Biomedicine
13
31
.
Lars Hagmeyer & Martin Kolb. 2016. Seltene Lungenerkrankungen. Seltene Lungenerkrankungen
127
141
.
Susan K. Mathai, Ivana V. Yang, Marvin I. Schwarz & David A. Schwartz. (2015) Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis. BMC Medicine 13:1.
Crossref
Crossref
Pierre-Simon Bellaye & Martin Kolb. (2015) Why do patients get idiopathic pulmonary fibrosis? Current concepts in the pathogenesis of pulmonary fibrosis. BMC Medicine 13:1.
Crossref
Crossref
Cathy Sampson, Ben Hope Gill, Nicholas Kim Harrison, Annmarie Nelson & Anthony Byrne. (2015) The care needs of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study. BMC Pulmonary Medicine 15:1.
Crossref
Crossref
Brett Ley & Harold R. Collard. (2015) House of Cards? Testing Fundamental Assumptions in Idiopathic Pulmonary Fibrosis Epidemiology. American Journal of Respiratory and Critical Care Medicine 192:10, pages 1147-1148.
Crossref
Crossref
Subbiah Rajasekaran, P. Rajaguru & P. S. Sudhakar Gandhi. (2015) MicroRNAs as potential targets for progressive pulmonary fibrosis. Frontiers in Pharmacology 6.
Crossref
Crossref
Ivana V. Yang, Tasha E. Fingerlin, Christopher M. Evans, Marvin I. Schwarz & David A. Schwartz. (2015) MUC5B and Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society 12:Supplement 2, pages S193-S199.
Crossref
Crossref
John Hutchinson, Andrew Fogarty, Richard Hubbard & Tricia McKeever. (2015) Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. European Respiratory Journal 46:3, pages 795-806.
Crossref
Crossref
S. Gavini, R. T. Finn, W.-K. Lo, H. J. Goldberg, R. Burakoff, N. Feldman & W. W. Chan. (2015) Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients. Neurogastroenterology & Motility 27:9, pages 1326-1332.
Crossref
Crossref
Britney A. Helling & Ivana V. Yang. (2015) Epigenetics in lung fibrosis. Current Opinion in Pulmonary Medicine 21:5, pages 454-462.
Crossref
Crossref
Yuta Tanaka, Yoichi Ishitsuka, Marina Hayasaka, Yusei Yamada, Keishi Miyata, Motoyoshi Endo, Yuki Kondo, Hiroshi Moriuchi, Mitsuru Irikura, Ken-ichiro Tanaka, Tohru Mizushima, Yuichi Oike & Tetsumi Irie. (2015) The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice. Pharmacological Research 99, pages 52-62.
Crossref
Crossref
Vincent Cottin. (2015) Nintedanib: a new treatment for idiopathic pulmonary fibrosis. Clinical Investigation 5:7, pages 621-632.
Crossref
Crossref
Mariano E. Mazzei, Luca Richeldi & Harold R. Collard. (2015) Nintedanib in the treatment of idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease 9:3, pages 121-129.
Crossref
Crossref
Tao Xu, Bao-Ming Wu, Hong-Wei Yao, Xiao-Ming Meng, Cheng Huang, Ming-Ming Ni & Jun Li. (2015) Novel Insights Into TRPM7 Function in Fibrotic Diseases: A Potential Therapeutic Target. Journal of Cellular Physiology 230:6, pages 1163-1169.
Crossref
Crossref
Ena Ray Banerjee, Srabani Kar, Surajlata Konsam, Garima Hore, Shinjini Mitra, Silpak Biswas, Aryabaran Sinha & Nikhil Ranjan Jana. (2015) Therapeutic use of fisetin, curcumin, and mesoporous carbon nanoparticle loaded fisetin in bleomycin-induced idiopathic pulmonary fibrosis. Biomedical Research and Therapy 2:4.
Crossref
Crossref
Vasilios Tzilas & Demosthenes Bouros. (2015) Inherent weaknesses of the current ICD coding system regarding idiopathic pulmonary fibrosis. European Respiratory Journal 45:4, pages 1194-1196.
Crossref
Crossref
R.N.C. Lee, E. Kelly, G. Nolan, S. Eigenheer, D. Boylan, D. Murphy, J. Dodd, M.P. Keane & W.T. McNicholas. (2015) Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers. QJM 108:4, pages 315-323.
Crossref
Crossref
Carla Daniela Robles-Espinoza, Martin del Castillo Velasco-Herrera, Nicholas K. Hayward & David J. Adams. (2015) Telomere-Regulating Genes and the Telomere Interactome in Familial Cancers. Molecular Cancer Research 13:2, pages 211-222.
Crossref
Crossref
Displaying 200 of 208 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list